ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
US Tech 100
18,488.00
-0.25%
Dow Jones
38,798.99
-0.22%
Brent Oil
79.395
0.00%
Bitcoin
69,326.81
-0.01%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immatics NV (IMTX)

  7. Immatics NV (IMTX) News

IMTX

Immatics NV (IMTX)

Immatics NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMTX
DateTimeSourceHeadlineSymbolCompany
05/14/20247:00AMGlobeNewswire Inc.Immatics Announces First Quarter 2024 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
03/21/20247:00AMGlobeNewswire Inc.Immatics Announces Full Year 2023 Financial Results and Corporate UpdateNASDAQ:IMTXImmatics NV
01/22/202412:52PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
01/19/20248:58AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMTXImmatics NV
01/17/20248:30PMGlobeNewswire Inc.Immatics Announces Pricing of $175 Million Public OfferingNASDAQ:IMTXImmatics NV
01/17/20244:11PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMTXImmatics NV
01/17/20244:01PMGlobeNewswire Inc.Immatics Announces Proposed Public OfferingNASDAQ:IMTXImmatics NV
01/16/20244:06AMPR Newswire (US)DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed FinancingNASDAQ:IMTXImmatics NV
01/16/20243:59AMPR Newswire (US)DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed FinancingNASDAQ:IMTXImmatics NV
11/30/20234:00AMGlobeNewswire Inc.Levicept Appoints Eliot Forster as CEONASDAQ:IMTXImmatics NV
11/14/20237:00AMGlobeNewswire Inc.Immatics Announces Third Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
11/08/20237:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
11/08/20237:00AMGlobeNewswire Inc.Immatics Reports Interim Clinical Data from ACTengine® IMA203 and IMA203CD8 TCR-T Monotherapies Targeting PRAME in an Ongoing Phase 1 TrialNASDAQ:IMTXImmatics NV
10/24/20237:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
10/24/20237:00AMGlobeNewswire Inc.Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T MonotherapyNASDAQ:IMTXImmatics NV
09/14/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IMTXImmatics NV
09/13/20235:03PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IMTXImmatics NV
09/11/20237:00AMGlobeNewswire Inc.Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology TherapeuticsNASDAQ:IMTXImmatics NV
09/11/20236:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
08/25/20234:11PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:IMTXImmatics NV
08/17/20237:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
08/17/20237:00AMGlobeNewswire Inc.Immatics Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
08/10/20237:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
08/10/20237:00AMGlobeNewswire Inc.Immatics Initiates Phase 1/2 Clinical Trial to Evaluate PRAME TCR Bispecific IMA402 in Patients with Advanced Solid TumorsNASDAQ:IMTXImmatics NV
07/24/20237:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMTXImmatics NV
07/24/20237:00AMGlobeNewswire Inc.Immatics Announces $35 Million Equity Investment from Bristol Myers SquibbNASDAQ:IMTXImmatics NV
06/20/20234:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMTXImmatics NV
05/16/20237:06AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:IMTXImmatics NV
05/16/20237:00AMGlobeNewswire Inc.Immatics Announces First Quarter 2023 Financial Results and Business UpdateNASDAQ:IMTXImmatics NV
05/02/20237:00AMGlobeNewswire Inc.Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine® IMA203 TCR-T Targeting PRAMENASDAQ:IMTXImmatics NV
 Showing the most relevant articles for your search:NASDAQ:IMTX

Your Recent History

USOTC
RHCGF
Ryman Healthcare (PK)
LSE
68LD
Consort H.2.97%
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved